MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression.

Wang, Yilang; Chen, Xiaohong; Yao, Ninghua; Gong, Jun; Cao, Yongfeng; Su, Xiaoqing; Feng, Xiu; Tao, Min

Wang, Yilang; Chen, Xiaohong; Yao, Ninghua; Gong, Jun; Cao, Yongfeng; Su, Xiaoqing; Feng, Xiu; Tao, Min.

Afiliação

Wang Y; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Chen X; Department of Medical Oncology, The Affiliated Tumor Hospital of Nantong University, Nantong, China.
Yao N; Department of Ultrasound Medicine, The Second Affiliated Hospital of Nantong University, Nantong, China.
Gong J; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Cao Y; Department of Medical Oncology, The Affiliated Tumor Hospital of Nantong University, Nantong, China.
Su X; Department of Medical Oncology, The Affiliated Tumor Hospital of Nantong University, Nantong, China.
Feng X; Department of Medical Oncology, The Affiliated Tumor Hospital of Nantong University, Nantong, China.
Tao M; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.

J Gastrointest Oncol ; 13(1): 355-367, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35284123

Palavras-chave

Hepatocellular carcinoma (HCC); apoptosis; glycolysis; insulin-like growth factor 1 receptor (IGF-1R); miR-448

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Gastrointest Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google